Globus Medical (GMED)
Working capital turnover
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue (ttm) | US$ in thousands | 2,519,355 | 2,478,596 | 2,236,530 | 1,898,454 | 1,568,476 | 1,226,440 | 1,096,949 | 1,068,982 | 1,022,843 | 998,366 | 973,939 | 961,307 | 958,102 | 941,526 | 927,903 | 825,809 | 789,042 | 767,264 | 747,381 | 792,998 |
Total current assets | US$ in thousands | 2,177,260 | 2,056,530 | 1,923,890 | 1,828,570 | 1,915,370 | 1,917,340 | 1,210,010 | 1,070,430 | 983,344 | 920,001 | 891,168 | 916,598 | 864,516 | 980,514 | 891,998 | 814,373 | 821,765 | 811,951 | 696,891 | 641,800 |
Total current liabilities | US$ in thousands | 855,913 | 818,065 | 794,146 | 786,324 | 392,347 | 428,722 | 155,220 | 167,547 | 159,204 | 145,255 | 146,017 | 141,491 | 140,164 | 122,525 | 130,042 | 123,677 | 120,792 | 99,980 | 106,126 | 97,962 |
Working capital turnover | 1.91 | 2.00 | 1.98 | 1.82 | 1.03 | 0.82 | 1.04 | 1.18 | 1.24 | 1.29 | 1.31 | 1.24 | 1.32 | 1.10 | 1.22 | 1.20 | 1.13 | 1.08 | 1.27 | 1.46 |
December 31, 2024 calculation
Working capital turnover = Revenue (ttm) ÷ (Total current assets – Total current liabilities)
= $2,519,355K ÷ ($2,177,260K – $855,913K)
= 1.91
Working capital turnover is a financial ratio that provides insight into how efficiently a company is utilizing its working capital to generate sales. Globus Medical's working capital turnover has fluctuated over the past few years, ranging from a low of 0.82 to a high of 2.00.
Initially, in March 2020, Globus Medical had a working capital turnover of 1.46, indicating that the company was able to generate $1.46 in sales for every dollar of working capital invested. Subsequently, the ratio decreased to 1.08 by September 2020, suggesting a potential inefficiency in working capital management.
However, the ratio showed signs of improvement in the following quarters, reaching a peak of 2.00 in September 2024. This indicates that Globus Medical effectively utilized its working capital to generate sales during that period.
Overall, the fluctuation in Globus Medical's working capital turnover may signify varying levels of efficiency in managing its working capital to drive sales. It is essential for the company to consistently monitor and optimize its working capital turnover to support sustainable growth and profitability.
Peer comparison
Dec 31, 2024